Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: Its prognostic value on short-term recurrences
- 31 December 1993
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 29 (11), 1509-1513
- https://doi.org/10.1016/0959-8049(93)90284-m
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Cell kinetics of human tumors by in vitro bromodeoxyuridine labeling.Journal of Histochemistry & Cytochemistry, 1989
- Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow CytometryNew England Journal of Medicine, 1989
- Immunological Determination of Labeling Index on Human Tumor Tissue Sections Using Monoclonal Anti-Brdurd AntibodyStain Technology, 1986
- Cell kinetics as a prognostic marker in node-negative breast cancerCancer, 1985
- The long‐term prognostic significance of the thymidine labelling index in breast cancerInternational Journal of Cancer, 1984
- Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP updateCancer, 1983
- Prediction of early course of breast carcinoma by thymidine labelingCancer, 1983
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983
- Monoclonal Antibody to 5-Bromo- and 5-Iododeoxyuridine: A New Reagent for Detection of DNA ReplicationScience, 1982
- Long-term followup of breast cancer patients: The 30-year reportCancer, 1974